These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9057777)
1. Reteplase (Retavase). Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777 [No Abstract] [Full Text] [Related]
2. Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction. Amsterdam EA Pharmacotherapy; 1996; 16(5 Pt 2):137S-140S. PubMed ID: 8888101 [TBL] [Abstract][Full Text] [Related]
3. Reteplase set to enter thrombolytic market. Am J Health Syst Pharm; 1997 Jan; 54(1):12. PubMed ID: 9117779 [No Abstract] [Full Text] [Related]
4. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Noble S; McTavish D Drugs; 1996 Oct; 52(4):589-605. PubMed ID: 8891469 [TBL] [Abstract][Full Text] [Related]
5. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics. Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data. Wilcox RG Am J Cardiol; 1996 Dec; 78(12A):20-3. PubMed ID: 8990407 [TBL] [Abstract][Full Text] [Related]
7. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents]. Huber K Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902 [TBL] [Abstract][Full Text] [Related]
8. The results of arterial thrombolysis. Kroese AJ; Staxrud LE Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078 [No Abstract] [Full Text] [Related]
13. Molecular biology of plasminogen activators: what are the clinical implications of drug design? Smalling RW Am J Cardiol; 1996 Dec; 78(12A):2-7. PubMed ID: 8990404 [TBL] [Abstract][Full Text] [Related]
14. Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction. Gurbel PA; Dalesandro MR; Serebruany VL Thromb Haemost; 1998 Oct; 80(4):725. PubMed ID: 9799011 [No Abstract] [Full Text] [Related]
15. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]